Cargando…
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
Autores principales: | De Greef, Julien, Devresse, Arnaud, Saad Albichr, Imane, Scohy, Anais, Kanaan, Nada, Georgery, Hélène, Belkhir, Leila, Kabamba, Benoit, Yombi, Jean Cyr, Goffin, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405446/ https://www.ncbi.nlm.nih.gov/pubmed/34478748 http://dx.doi.org/10.1016/j.kint.2021.08.018 |
Ejemplares similares
-
Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination
por: Saad Albichr, Imane, et al.
Publicado: (2023) -
High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021) -
In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)